Dtsch Med Wochenschr 2011; 136(11): 548-550
DOI: 10.1055/s-0031-1274540
Kommentar | Commentary
Endokrinologie
© Georg Thieme Verlag KG Stuttgart · New York

Energie, braunes Fettgewebe und Adipositas

Energy, brown adipose tissue, obesityM. Merkel1 , J. Heeren2
  • 11. Medizinische Abteilung, Asklepios Klinik St. Georg, Hamburg
  • 2Institut für Biochemie, IBM2, Universitätsklinikum Hamburg-Eppendorf
Weitere Informationen

Publikationsverlauf

eingereicht: 19.12.2010

akzeptiert: 3.3.2011

Publikationsdatum:
08. März 2011 (online)

Literatur

  • 1 Agarwal A K, Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.  Trends Endocrinol Metab. 2003;  14 214-221
  • 2 Balkau B, Deanfield J E, Despres J P. et al . International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.  Circulation. 2007;  116 1942-1951
  • 3 Bartelt A, Bruns O T, Reimer R. et al . Brown adipose tissue activity controls triglyceride clearance.  Nat Med. 2011;  17 200-205
  • 4 Cypess A M, Lehman S, Williams G. et al . Identification and importance of brown adipose tissue in adult humans.  N Engl J Med. 2009;  360 1509-1517
  • 5 Elmquist J K. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin.  Physiol Behav. 2001;  74 703-708
  • 6 Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ.  Cell Metab. 2010;  11 253-256
  • 7 Hamann A, Flier J S, Lowell B B. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia.  Endocrinology. 1996;  137 21-29
  • 8 Hany T F, Gharehpapagh E, Kamel E M, Buck A, Himms-Hagen J, von Schulthess G K. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region.  Eur J Nucl Med Mol Imaging. 2002;  29 1393-1398
  • 9 Hummasti S, Hotamisligil G S. Endoplasmic reticulum stress and inflammation in obesity and diabetes.  Circ Res. 2010;  107 579-591
  • 10 International Diabetes Foundation (IDF) .Diabetes-Atlas. 2010 http://www.diabetesatlas.org/
  • 11 Kajimura S, Seale P, Kubota K. et al . Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.  Nature. 2009;  460 1154-1158
  • 12 Kajimura S, Seale P, Spiegelman B M. Transcriptional control of brown fat development.  Cell Metab. 2010;  11 257-262
  • 13 Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak L P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity.  J Clin Invest. 1995;  96 2914-2923
  • 14 Lean M E. Brown adipose tissue in humans.  Proc Nutr Soc. 1989;  48 243-256
  • 15 Lee P, Greenfield J R, Ho K K, Fulham M J. A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans.  Am J Physiol Endocrinol Metab. 2010;  299 E601-606
  • 16 Lowell B B, V S S, Hamann A. et al . Development of obesity in transgenic mice after genetic ablation of brown adipose tissue.  Nature. 1993;  366 740-742
  • 17 Muller-Wieland D, Knebel B, Haas J, Merkel M, Kotzka J. Adipositas: ektope Fettverteilung und Herz.  Herz. 2010;  35 198-205
  • 18 Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans.  Am J Physiol Endocrinol Metab. 2007;  293 E444-452
  • 19 Oral E A, Simha V, Ruiz E. et al . Leptin-replacement therapy for lipodystrophy.  N Engl J Med. 2002;  346 570-578
  • 20 Unger R H, Clark G O, Scherer P E, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome.  Biochim Biophys Acta. 2010;  1801 209-214
  • 21 van Marken L ichtenbelt WD, Vanhommerig J W, Smulders N M. et al . Cold-activated brown adipose tissue in healthy men.  N Engl J Med. 2009;  360 1500-1508
  • 22 Virtanen K A, Lidell M E, Orava J. et al . Functional brown adipose tissue in healthy adults.  N Engl J Med. 2009;  360 1518-1525

PD Dr. med. Martin Merkel

Oberarzt
Asklepios Klinik St. Georg
1. Medizinische Abteilung
(Diabetes, Stoffwechsel, Endokrinologie, Gastroenterologie und Allgemeine Innere Medizin)

Lohmühlenstr. 5

20099 Hamburg

Telefon: 040/18 18-85 2352

Fax: 040/18 18-85 2323

eMail: m.merkel@asklepios.com